Andreessen Horowitz

Andreessen Horowitz is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz and based in Menlo Park, California. It funds startups across the entire lifecycle, from seed to growth, with a broad focus on software and technology-enabled businesses. The firm backs companies in software, cloud infrastructure, digital platforms, data storage, and mobile and Internet services, as well as sectors at the intersection of technology with life sciences, such as bio healthcare and computational medicine. Its investments span artificial intelligence, fintech, consumer and enterprise software, crypto and blockchain, cybersecurity, and related infrastructure. Through strategic guidance and a hands-on approach, the firm aims to help portfolio companies scale and innovate.

Leila Abu-Sharr

Partner, Market Development

Anish Acharya

General Partner

Vineeta Agarwala

General Partner

Eric Alby

Partner

Ryan Allen

Partner

Seema Amble JD

Partner

Katia Ameri

Partner

Jeff Amico JD

Partner and Director of Crypto Startup School

Marc Andreessen

General Partner

Marc Andrusko

Partner

Alicia Barone

Events Partner

Peter Blackwood

Partner

Michael Blau

Partner

Matt Bornstein

Partner

Katherine Boyle

General Partner

Jeff Bramel

Partner

Sam Broner

Partner

Parker Brown

Partner

Elena Burger

Deal Partner

Quinten Burgunder

Partner

LeeAnn Caballero

Partner

Martin Casado

General Partner

Connie Chan

General Partner

Sharon Chang

Operating Partner

Zachary Chen

Associate Partner

Frank Chen

Partner

Alexander Chia

Partner

Zach Cohen

Investor

Annie Collins

Partner

Emma Cooper

Investor

Michael Copeland

Partner

Brian Crnkovich

Partner

Sebastian Cua

Partner and Chief of Staff

Stacy D'Amico

Co-COO, Growth fund

Eric Dai

Analyst

Allison Davis

Partner

Alyssa Del Bene

Partner

Zach Dicker

Partner

Chris Dixon

Managing Partner

Jay Drain Jr.

Deal Partner

Kevin Dulsky

Partner

Grace Ellis

Operating Partner

JT Evans

Partner

Bryan Faust

Partner

Sarah Fazal

Partner

Ethan Ferreira

Partner

Pamon Forouhar

Partner, Business Operations

Surya Ganguli Ph.D

Venture Partner

John Garcia

Firm Operations Partner

David Garcia

Partner

David George

General Partner

Caroline Goggins

Partner

Kristina Graci-deLuna

Partner, People Practice

Emily Graff

Partner

Lydia Green

Deal Operations Partner

Grant Gregory

Partner

Michele Griffin

Partner

Robin Guo

Partner

Austin Guzman

Partner

David Haber

General Partner

Andrea Hall

Partner on the Go-to-Market team

Mason Hall

Partner

Tom Hammer

Partner

Elizabeth Harkavy

Partner

Ronnie Harris II

Partner

Tawny Holguin

Partner

Oliver Hsu

Partner

Nicole Irvin

Partner

Mindy Isenstein

Partner

Peter Johnson

Partner

Justin Kahl

Partner

Amy Kalokerinos

Partner

Brad Kern

Operating Partner

Blake Kim

Partner

Brett Kim

Investor

Bryan Kim

Partner

Troy Kirwin

Partner

James Kissell

Partner, GTM Network

William Krause

Board Partner

Scott Kupor

Managing Partner

Zane Lackey

General Partner

Jonathan Lai

General Partner

Justin Larkin

Partner

Peter Lauten

Partner

Andrew Lee

Partner

Peter Levine

General Partner

Yoko Li

Partner

Jennifer Li

Partner

Ginger Liau

Partner, Bio Fund

Jane Lippencott

Partner

Kristine Lipscomb

Partner

Bowen Liu

Investing Partner

Seth Lobree

Partner

Insiya Lokhandwa

Partner

Insiya Lokhandwala

Partner

Isaiah Lott

Partner

Josh Lu

Investing Partner, GAMES FUND ONE

Joshua Lu

Investing Partner, Games Fund One

Valentina Marzorati

Partner

Marco Mascorro

Partner

Daren Matsuoka

Partner

Mark McAndrew

Partner

Ryan McEntush

Partner

Taylor McFadden

People Practices Partner

Mehul Mehta

Deal Partner

Michelle V.

Investment Partner

Anjney Midha

General Partner

Jeanne Moeschler

Partner

Jason Mok

Operating Partner, Corporate Development

Olivia Moore

Partner

Ana Mostarac

Corporate Development Partner

Kevin Nishioka

Partner

John O’Farrell

General Partner

Wahab Owolabi

Partner

Steve Papa

Board Partner

Nelson Perla-Ward

Partner

Jessica Peterson

Partner - EBC Program and Operations Manager

Rebecca (Becky) Pferdehirt

Partner

Jewel Pi

Partner

Ben Portney

Investment Partner

Erin Price-Wright

Partner

Manas Punhani

Partner

Rajko Radovanovic

Partner

Sam Ragsdale

Investor

Alex Rampell

General Partner

Justin Roberts

Partner

Santiago Rodriguez Lebrija

Partner

Maggie Romero

Co-COO and Operating Partner, Bio+Health

Jason Rosenthal

Operating Partner and Head of Crypto Startup Accelerator

Jay Rughani

Partner

Katherine Rundell

Partner, Creators and Consumer GTM

Michael Sandwick

Partner, Consumer

Shannon Schiltz

Operating Partner

Joe Schmidt

Partner

Gil Shafir

Partner

Ian Shannon

Partner, Corporate Council

Kristina Shen

General Partner

Laura Shores

Partner

Jeffrey Silverstein

Partner

Sumeet Singh

Partner

Anne Lee Skates

Partner

Andrew Smith

Partner

Mariano Sorgente

Partner

Jack Soslow

Partner

Matt Spence JD

Partner

Jeff Stump

Operating Partner

Jamie Sullivan

Partner

Bob Swan

Partner

Satish Talluri

Partner

Kimberly Tan

Partner

Carol Tang

Partner

Sam Thompson

Partner

Adela Tomsejova

Partner, Bio + Health

Dalton Turay

Partner

David Ulevitch

General Partner

Gabriel Vasquez

Partner

Michelle Volz

Partner

Melissa Wasser

Partner, Capital Network

Daisy Wolf

Partner

Carra Wu

Partner

Kevin Wu

Partner

Guy Wuollet

Partner

Shangda Xu

Partner

Ali Yahya

General Partner

Zeya Yang

Partner

Julie Yoo

General Partner

JJ Yu

Partner, Capital Network

Joel de la Garza

Partner

Past deals in Healthcare

Thatch

Series B in 2025
Thatch is a digital platform designed to streamline employee healthcare management for businesses. It offers an AI-driven assistant, ThatchBot, which provides round-the-clock support for employees' healthcare queries and expense tracking. The platform enables companies to set personalized healthcare budgets for each employee, fostering tailored healthcare experiences and efficient benefits navigation.

Juniper Behavioral Health

Series B in 2025
Juniper develops a behavioral health practice management software designed to streamline the logistical operations of clinics. The platform integrates various functions, including patient onboarding and billing, into a single cohesive system. It focuses on reducing manual tasks that clinicians typically encounter, thereby enhancing efficiency. Additionally, Juniper's software emphasizes compatibility with third-party applications, allowing for better automation and accountability across clinic operations. This holistic approach enables clinics to improve their reporting capabilities and manage their databases more effectively, ultimately supporting their growth and operational scalability.

Slingshot AI

Series A in 2025
Slingshot AI is a research company dedicated to enhancing global access to mental healthcare through artificial intelligence. Based in New York City and London, the company develops advanced large language models to understand human psychology deeply, empowering individuals to cope with daily challenges and seek mental support.

Hippocratic AI

Series B in 2025
Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Infinitus Systems

Series C in 2024
Infinitus Systems automates phone calls in healthcare using AI. It streamlines administrative tasks like insurance eligibility checks, improving efficiency, reducing costs, and enhancing patient care.

Tennr

Series B in 2024
Tennr is a healthcare technology company that develops an AI-powered platform to automate back-office operations in healthcare. The solution replaces traditional fax-based workflows and streamlines communication, enabling timely patient care. It tracks the lifecycle of patient referrals and automates tasks such as data entry verification and workflow progression, reducing manual work for staff and allowing practices of all sizes to optimize back-office processes with enterprise-quality automation.

Alchemy

Seed Round in 2024
Alchemy creates and implements clinical pharmacy programs and deploys technology products that use the pharmacy to expand access for patients, improve health outcomes, and increase the financial impact of a clinic's pharmacy program.

Scribenote

Seed Round in 2024
Scribenote is a technology company specializing in AI-driven medical scribe solutions for veterinarians. Its platform automates and simplifies the documentation process, reducing administrative tasks and allowing veterinarians to focus more on patient care. The system captures audio, generates transcripts, and creates SOAP notes during appointments, integrating seamlessly with practice management software. This streamlines workflows, enhances client experience, and improves overall efficiency in veterinary clinics.

GC Therapeutics

Series A in 2024
GC Therapeutics employs synthetic biology to transform patient-derived stem cells into diverse cell types efficiently and at scale. The company has validated its technology across multiple applications, creating SuperCellsâ„¢ tailored for specific conditions. Originally developed in Professor George Church's lab at Harvard Medical School, GC Therapeutics is dedicated to bringing this innovative method to patients.

Thatch

Series A in 2024
Thatch is a digital platform designed to streamline employee healthcare management for businesses. It offers an AI-driven assistant, ThatchBot, which provides round-the-clock support for employees' healthcare queries and expense tracking. The platform enables companies to set personalized healthcare budgets for each employee, fostering tailored healthcare experiences and efficient benefits navigation.

Levels

Series A in 2024
Levels develops a health and wellness platform that monitors metabolic fitness by tracking blood glucose in real time, enabling users to optimize their diet and exercise. The company offers a wellness wearable device paired with a platform that provides real-time feedback on how the body responds to dietary and lifestyle choices, helping users tailor their routines to personal goals. Founded in 2019, Levels operates as a remote-first company focused on helping individuals understand their metabolism to improve health outcomes.

Headway

Series D in 2024
Headway is a leading data-driven media buying company for marketers. It integrates innovative technology with partner platforms to deliver smart cross-channel services, making ads more relevant and driving consumer engagement.

Q Bio

Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Formation Bio

Series D in 2024
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.

Talkiatry

Series C in 2024
Talkiatry is a provider of virtual, in-network psychiatry services, connecting patients with a team of over 300 licensed psychiatrists. The company focuses on delivering evaluation, diagnosis, and personalized treatment plans, including medication management, for various mental health conditions such as anxiety, depression, ADHD, and substance use disorders. By employing an interactive process with evidence-based scales, Talkiatry facilitates on-the-spot preliminary diagnoses and assessments, thereby enhancing access to quality mental health care. The company's mission is to make high-quality psychiatric services both accessible and convenient for patients seeking treatment.

Santa Ana Bio

Series B in 2024
Santa Ana Bio is a biotechnology company specializing in the development of precision immunology therapies for autoimmune diseases. It employs advanced multi-omics platforms and antibody engineering techniques to design targeted biologics, aiming to improve patient outcomes and quality of life.

Valar Labs

Series A in 2024
Valar Labs, founded in 2021 by Anirudh Joshi, Viswesh Krishna, Pranav Rajpurkar, and Damir Vrabac, is a healthcare technology company focused on enhancing cancer treatment through the use of artificial intelligence. The company has developed a software platform that analyzes imaging data, which is routinely collected in clinical settings, to provide oncologists with interpretable and actionable insights. By leveraging patient-specific characteristics, Valar Labs aims to support oncologists in making informed treatment decisions, ultimately improving patient outcomes in cancer care.

xAI

Series B in 2024
XAI is a technology company specializing in artificial intelligence. It creates and deploys AI solutions, primarily using machine learning, to enhance data analysis and decision-making processes. XAI caters to the finance, healthcare, and logistics sectors, aiming to improve accuracy and efficiency in these industries.

Tennr

Series A in 2024
Tennr is a healthcare technology company that develops an AI-powered platform to automate back-office operations in healthcare. The solution replaces traditional fax-based workflows and streamlines communication, enabling timely patient care. It tracks the lifecycle of patient referrals and automates tasks such as data entry verification and workflow progression, reducing manual work for staff and allowing practices of all sizes to optimize back-office processes with enterprise-quality automation.

Hippocratic AI

Series A in 2024
Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Milu Health

Seed Round in 2024
Milu Health is a healthcare platform focused on simplifying and reducing the costs associated with medical care for employees. By leveraging electronic health records, claims, and pricing data, the company identifies cost-saving opportunities in healthcare. Milu Health provides price transparency data that helps users find high-quality, reasonably-priced doctors and hospitals for common procedures and surgeries. This enables patients to make informed decisions regarding their healthcare, ultimately leading to savings on doctor visits, procedures, prescription drugs, and medical bills.

Ambience Healthcare

Series B in 2024
Ambience Healthcare is a developer of an advanced artificial intelligence-powered medical scribe that aims to enhance clinician efficiency and alleviate burnout. Its Ambience AI operating system features a suite of synergistic applications designed to capture the nuances of clinician-patient conversations in real-time, generating comprehensive notes that integrate seamlessly into electronic medical record workflows. The system employs state-of-the-art speech recognition and custom-built AI to produce documentation in seconds while accommodating individual clinician preferences to reflect their unique style and voice. By utilizing Ambience's technology, healthcare systems can significantly reduce documentation time by an average of 78%, improve coding integrity, and achieve substantial returns on investment, ultimately enabling clinicians to close all their charts by the end of their shifts and achieve a better work-life balance.

Turquoise Health

Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.

Talofa

Seed Round in 2024
Talofa is building games that make players mentally and physically healthier. Their flagship game on the platform, Run Legends, got over 300,000 downloads in the first 3 months and was featured as one of the "Best New Games" by Apple and Google Play Stores. Talofa’s team has been built up with game veterans from EA, 2K, and Riot Games and the CEO, Jenny Xu, has created mobile games with over 10M downloads.

Fortuna Health

Seed Round in 2023
Fortuna Health specializes in simplifying Medicaid access for consumers. Its core business is a user-friendly platform that guides individuals through the complexities of eligibility, enrollment, and renewal processes, ensuring they maintain continuous coverage and receive timely notifications for recertification and renewal. This streamlined approach helps reduce care gaps and ensures clients are enrolled in the most suitable medical plan programs.

Waymark

Venture Round in 2023
Waymark is a healthcare company focused on improving access to and quality of care for Medicaid beneficiaries. It delivers community-based services and collaborates with primary care providers to enhance access and health outcomes for patients enrolled in Medicaid. The company provides health plans, insulin education, and training, and creates employment opportunities for community-based care teams, supporting coordinated care and patient engagement so beneficiaries can monitor and manage their health.

Mana.bio

Seed Round in 2023
Mana.bio is an AI-driven company specializing in drug delivery for gene therapies, including DNA and RNA-based treatments, and vaccines. It employs machine learning and nanotechnology to develop lipid nanoparticle formulations.

Headway

Series C in 2023
Headway is a leading data-driven media buying company for marketers. It integrates innovative technology with partner platforms to deliver smart cross-channel services, making ads more relevant and driving consumer engagement.

Betterleap

Seed Round in 2023
Betterleap is a healthcare recruitment platform designed to simplify career advancement for professionals in patient care. It offers curated job listings, personalized recommendations, and a user-friendly mobile app to help users find roles aligned with their skills, aspirations, and values.

Bold

Series A in 2023
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.

Inceptive

Series A in 2023
Inceptive specializes in designing RNA molecules using large-scale deep learning algorithms, combined with high-throughput experiments. Their platform enables the creation of novel medicines and biotechnologies, making advanced biological software more accessible.

Caresync.website

Series A in 2023
Our telemedicine platform aims to transform the way healthcare is accessed, offering patients the flexibility to connect with trusted healthcare providers anytime, anywhere. Through our intuitive interface and advanced video conferencing capabilities, we enable seamless communication and personalized care delivery.

Hippocratic AI

Seed Round in 2023
Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Memora Health

Venture Round in 2023
Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Zus Health

Series A in 2023
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Thatch

Pre Seed Round in 2023
Thatch is a digital platform designed to streamline employee healthcare management for businesses. It offers an AI-driven assistant, ThatchBot, which provides round-the-clock support for employees' healthcare queries and expense tracking. The platform enables companies to set personalized healthcare budgets for each employee, fostering tailored healthcare experiences and efficient benefits navigation.

Thatch

Seed Round in 2023
Thatch is a digital platform designed to streamline employee healthcare management for businesses. It offers an AI-driven assistant, ThatchBot, which provides round-the-clock support for employees' healthcare queries and expense tracking. The platform enables companies to set personalized healthcare budgets for each employee, fostering tailored healthcare experiences and efficient benefits navigation.

Levels

Series A in 2023
Levels develops a health and wellness platform that monitors metabolic fitness by tracking blood glucose in real time, enabling users to optimize their diet and exercise. The company offers a wellness wearable device paired with a platform that provides real-time feedback on how the body responds to dietary and lifestyle choices, helping users tailor their routines to personal goals. Founded in 2019, Levels operates as a remote-first company focused on helping individuals understand their metabolism to improve health outcomes.

Pearl Health

Venture Round in 2022
Pearl Health empowers primary care providers to deliver proactive healthcare, reducing total cost of care. Founded in 2020, it partners with thousands of providers across 44 states, offering a platform that enables fixed payments per member, clinical insights, and direct contracting assistance.

Firefly Health

Venture Round in 2022
Founded in 2016, Firefly Health delivers AI-driven virtual-first primary care. Its platform connects patients with healthcare professionals for convenient, continuous care, focusing on common conditions and women's health issues.

Rezo Therapeutics

Series A in 2022
Rezo Therapeutics is a biotechnology company that focuses on pioneering the integrated mapping of disease networks to develop precision therapeutics. Utilizing its proprietary Sequence to Systems to Drugs (SSD) platform, Rezo combines proteomics, genetics, structural biology, chemistry, and bioinformatics to create comprehensive maps of molecular disease networks. This innovative approach enables oncologists and researchers to identify novel targets and therapies with greater clarity and precision than traditional drug discovery methods. Initially concentrating on oncology, Rezo Therapeutics plans to expand its therapeutic focus through collaborations and partnerships, aiming to address a wide range of diseases.

Revero

Seed Round in 2022
Revero is an online clinic specializing in treating chronic conditions through a root-cause approach. It offers personalized treatments for autoimmune and metabolic conditions via nutrition therapy and remote medical care, aiming to improve patients' blood sugar levels, metabolic health, reduce inflammation, and restore gut health.

Cipher Skin

Venture Round in 2022
Cipher Skin Inc. is a technology company based in Denver, Colorado, founded in 2014. The company specializes in wearable technology that utilizes innovative mesh sensors to conform to the human body, enabling precise measurement and monitoring of vital data. Cipher Skin's platform captures three-dimensional motion data and biosignals, such as heart rate and oxygen saturation, without the need for cameras or bulky equipment. This technology provides actionable insights that can be trusted, allowing physical therapists and trainers to develop safe and effective programs by accurately assessing complex movements, particularly in the upper limbs. Through its advancements, Cipher Skin aims to create the largest and most accurate data DNA platform of the physical world.

Incredible Health

Series B in 2022
Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.

Vicinitas Therapeutics

Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Cartography Biosciences

Series A in 2022
Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.

Tomorrow Health

Series B in 2022
Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Locale

Seed Round in 2022
We create organic high-protein meals with high standards, backed by leading longevity research. Our standards: - 40-60g protein per meal - Nutrient-dense meat (grass-fed, pasture-raised, wild-caught) - No seed oils (cooked in extra virgin olive oil) - 8g+ fiber per meal - Organic, pesticide-free produce - No processed ingredients. No refined sugars - Microplastic-free, reusable glass jars - High in Anti-inflammatories, and Omega-3s Since starting in 2020, we’ve delivered 100K+ orders and are backed by a16z, Y-Combinator, Goodwater, Decent Capital, and other top investors.

Turquoise Health

Series A in 2022
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.

Octant Bio

Series B in 2022
Octant Bio is a company focused on developing synthetic technology to enhance health and treat diseases. The firm employs synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells simultaneously. This approach allows scientists to use machine learning methods to engineer small molecules that can interact with multiple receptors, offering new potential for treating complex diseases.

Memora Health

Venture Round in 2022
Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Topography Health

Series A in 2022
Topography Health facilitates private practice physicians' involvement in clinical trials. It assists practices in understanding patient populations, recommends suitable studies, recruits patients, and manages research staff, making personalized clinical trials more accessible.

Nitra

Seed Round in 2022
Nitra is a financial technology company focused on transforming the healthcare industry through innovative and efficient solutions. It provides a suite of machine learning-powered financial software that includes credit cards, loans, accounts, payments, and expense management tools specifically designed for medical professionals. Nitra's platform enables healthcare providers to streamline their financial operations, allowing them to balance patient care with practice management. Its offerings include a business card that rewards spending and fosters partnerships with various service providers, as well as user-friendly accounting and receipt reconciliation tools. Nitra is committed to equipping the healthcare sector with advanced technology and dedicated support, ensuring that financial management can be both effective and straightforward.

Waymark

Series A in 2022
Waymark is a healthcare company focused on improving access to and quality of care for Medicaid beneficiaries. It delivers community-based services and collaborates with primary care providers to enhance access and health outcomes for patients enrolled in Medicaid. The company provides health plans, insulin education, and training, and creates employment opportunities for community-based care teams, supporting coordinated care and patient engagement so beneficiaries can monitor and manage their health.

Ribbon Health

Series B in 2021
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the costs and quality of care. The platform offers services such as provider directories, referral management, care navigation, and insurance enrollment, catering to a diverse range of clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. Founded in 2016 and based in New York, the company was previously known as HealthWiz, Inc. before rebranding in March 2018. Ribbon Health provides the critical infrastructure necessary for accurate provider directories and efficient healthcare navigation, thereby enhancing the overall healthcare experience for its users.

Patina

Series A in 2021
Patina is a healthcare company reinventing primary care for older adults by delivering a human, personalized, on-demand care model designed to improve the healthcare and aging experience for seniors and their families. The approach centers on the specific needs and values of aging individuals, offering flexible access to care and enabling families and loved ones to participate as part of the care team. By focusing on dignity in aging and a coordinated, person-centered experience, Patina aims to align medical care with daily living and the goals of aging adults.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Pearl Health

Series A in 2021
Pearl Health empowers primary care providers to deliver proactive healthcare, reducing total cost of care. Founded in 2020, it partners with thousands of providers across 44 states, offering a platform that enables fixed payments per member, clinical insights, and direct contracting assistance.

ROME Therapeutics

Series B in 2021
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Turquoise Health

Seed Round in 2021
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.

Bayesian Health

Venture Round in 2021
Founded in 2016, Bayesian Health offers an AI-driven platform that integrates with hospital EMR systems. It provides real-time, actionable insights to healthcare teams by analyzing multi-layered clinical data sets, enabling timely decisions and improving patient care efficiency.

Zus Health

Series A in 2021
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Memora Health

Venture Round in 2021
Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Headway

Series B in 2021
Headway is a leading data-driven media buying company for marketers. It integrates innovative technology with partner platforms to deliver smart cross-channel services, making ads more relevant and driving consumer engagement.

Tomorrow Health

Series A in 2021
Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Firefly Health

Series B in 2021
Founded in 2016, Firefly Health delivers AI-driven virtual-first primary care. Its platform connects patients with healthcare professionals for convenient, continuous care, focusing on common conditions and women's health issues.

AKASA

Series B in 2021
AKASA specializes in AI-powered automation solutions tailored for healthcare revenue cycles. By applying advanced technologies like AI and LLMs, AKASA automates complex tasks, enhancing efficiency, accuracy, and completeness. This enables healthcare providers to improve revenue outcomes, allocate resources effectively, and achieve greater operational excellence.

Komodo Health

Series E in 2021
Komodo Health is a healthcare technology company that provides a data-driven platform for real-world health information and insights. Its Healthcare Map aggregates diverse patient data to enable real-time intelligence across patients, clinicians, and health systems. The software suite includes Aperture, Pulse, and Serenity, which reveal intricate connections, highlight opportunities to influence disease burden, and analyze patient cohorts to generate actionable insights. The platform applies artificial intelligence and advanced data science to deliver patient-level analytics to life sciences companies, payers, providers, and other stakeholders. By delivering transparency and market intelligence, Komodo Health supports decision-making aimed at closing care gaps, reducing disease burden, and enabling more value-driven care. The company was founded in 2014 and is headquartered in New York with an additional office in San Francisco.

Cedar

Series D in 2021
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

Bold

Seed Round in 2021
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.

EQRx

Series B in 2021
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

Levels

Seed Round in 2020
Levels develops a health and wellness platform that monitors metabolic fitness by tracking blood glucose in real time, enabling users to optimize their diet and exercise. The company offers a wellness wearable device paired with a platform that provides real-time feedback on how the body responds to dietary and lifestyle choices, helping users tailor their routines to personal goals. Founded in 2019, Levels operates as a remote-first company focused on helping individuals understand their metabolism to improve health outcomes.

FidoCure

Series A in 2020
FidoCure develops AI-driven precision medicine for canine cancer. It analyzes data from naturally occurring canine tumors using next-generation sequencing and clinical information to build a proprietary learning database for cancer analysis. The company provides genomic sequencing services and targeted therapy recommendations to veterinarians, enabling personalized treatment plans. By linking veterinary and human oncology, FidoCure advances comparative oncology, aims to improve outcomes for dogs and to inform drug development that benefits both pets and people.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

AKASA

Series A in 2020
AKASA specializes in AI-powered automation solutions tailored for healthcare revenue cycles. By applying advanced technologies like AI and LLMs, AKASA automates complex tasks, enhancing efficiency, accuracy, and completeness. This enables healthcare providers to improve revenue outcomes, allocate resources effectively, and achieve greater operational excellence.

PatientPing

Series C in 2020
PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Octant Bio

Series A in 2020
Octant Bio is a company focused on developing synthetic technology to enhance health and treat diseases. The firm employs synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells simultaneously. This approach allows scientists to use machine learning methods to engineer small molecules that can interact with multiple receptors, offering new potential for treating complex diseases.

Topography Health

Venture Round in 2020
Topography Health facilitates private practice physicians' involvement in clinical trials. It assists practices in understanding patient populations, recommends suitable studies, recruits patients, and manages research staff, making personalized clinical trials more accessible.

Tomorrow Health

Seed Round in 2020
Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Ribbon Health

Series A in 2020
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the costs and quality of care. The platform offers services such as provider directories, referral management, care navigation, and insurance enrollment, catering to a diverse range of clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. Founded in 2016 and based in New York, the company was previously known as HealthWiz, Inc. before rebranding in March 2018. Ribbon Health provides the critical infrastructure necessary for accurate provider directories and efficient healthcare navigation, thereby enhancing the overall healthcare experience for its users.

Q Bio

Series B in 2020
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Buck Stash

Series A in 2020
Buck Stash is a venture capital firm that specializes in seed, early, mid, and late stage investments. It prefers to invest in the social media business and technology sector, with a focus on software, back-end infrastructure, Internet infrastructure, cloud computing, enterprise software and services, consumer, business Internet, mobile Internet, consumer Internet, cloud computing, data-storage, social network browsers data-storage, consumer electronics, networking functions, software related biology, biotech, and medicine companies at the intersection of computer science and medicine

EQRx

Series A in 2020
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

Komodo Health

Series C in 2020
Komodo Health is a healthcare technology company that provides a data-driven platform for real-world health information and insights. Its Healthcare Map aggregates diverse patient data to enable real-time intelligence across patients, clinicians, and health systems. The software suite includes Aperture, Pulse, and Serenity, which reveal intricate connections, highlight opportunities to influence disease burden, and analyze patient cohorts to generate actionable insights. The platform applies artificial intelligence and advanced data science to deliver patient-level analytics to life sciences companies, payers, providers, and other stakeholders. By delivering transparency and market intelligence, Komodo Health supports decision-making aimed at closing care gaps, reducing disease burden, and enabling more value-driven care. The company was founded in 2014 and is headquartered in New York with an additional office in San Francisco.

Tmunity

Series B in 2019
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, that specializes in the development of innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, Tmunity focuses on harnessing the potential of T cells through novel technologies, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg). The company has developed advanced platforms that allow for precise control over T cell activation and direction in vivo, as well as proprietary methods for activating, expanding, and genetically engineering T cells sourced from peripheral blood, cord blood, and tumors. Tmunity aims to advance personalized next-generation immunotherapies and has a team of experts with extensive experience in T-cell biology and clinical development, enhancing its capability to conduct safe and effective clinical trials. Its robust manufacturing platform supports multi-center clinical studies across various therapeutic areas, positioning Tmunity at the forefront of immunotherapy innovation.

Incredible Health

Series A in 2019
Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.

Omada Health

Series D in 2019
Omada Health is a digital healthcare company that offers personalized programs to manage chronic conditions such as prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health. It combines professional coaching, connected devices, real-time data, and personalized feedback to deliver clinically meaningful results.

Health IQ

Series D in 2019
Health IQ is a health insurance marketplace focused on increasing health literacy and rewarding health-conscious individuals with lower insurance rates. The company aims to celebrate those dedicated to their health by providing them with affordable life and Medicare insurance options. Its platform utilizes users' current health status, health knowledge, and active lifestyles to better assess long-term health risks, allowing for more accurate insurance product recommendations. By promoting health literacy, Health IQ seeks to empower individuals to take control of their health and well-being while offering incentives for maintaining a healthy lifestyle.

FidoCure

Seed Round in 2019
FidoCure develops AI-driven precision medicine for canine cancer. It analyzes data from naturally occurring canine tumors using next-generation sequencing and clinical information to build a proprietary learning database for cancer analysis. The company provides genomic sequencing services and targeted therapy recommendations to veterinarians, enabling personalized treatment plans. By linking veterinary and human oncology, FidoCure advances comparative oncology, aims to improve outcomes for dogs and to inform drug development that benefits both pets and people.

Ciitizen

Series A in 2019
Ciitizen operates a platform empowering patients to collect, control, and securely share comprehensive health data, including genomic information, lab results, and advanced directives. Founded in 2017, the company aims to provide all individuals access to their complete health history, fostering better care coordination and research opportunities.

AKASA

Seed Round in 2019
AKASA specializes in AI-powered automation solutions tailored for healthcare revenue cycles. By applying advanced technologies like AI and LLMs, AKASA automates complex tasks, enhancing efficiency, accuracy, and completeness. This enables healthcare providers to improve revenue outcomes, allocate resources effectively, and achieve greater operational excellence.

Ciitizen

Venture Round in 2018
Ciitizen operates a platform empowering patients to collect, control, and securely share comprehensive health data, including genomic information, lab results, and advanced directives. Founded in 2017, the company aims to provide all individuals access to their complete health history, fostering better care coordination and research opportunities.

insitro

Series A in 2018
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Accolade

Series F in 2018
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.

Q Bio

Series A in 2018
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Health IQ

Series C in 2017
Health IQ is a health insurance marketplace focused on increasing health literacy and rewarding health-conscious individuals with lower insurance rates. The company aims to celebrate those dedicated to their health by providing them with affordable life and Medicare insurance options. Its platform utilizes users' current health status, health knowledge, and active lifestyles to better assess long-term health risks, allowing for more accurate insurance product recommendations. By promoting health literacy, Health IQ seeks to empower individuals to take control of their health and well-being while offering incentives for maintaining a healthy lifestyle.

Freenome

Series A in 2017
Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Shield Bio

Seed Round in 2017
Shield Bio is a biotechnology company focused on combating antibiotic resistance, a growing public health crisis projected to surpass cancer-related deaths by 2050. The company has developed a novel genomic testing platform that enables sexually transmitted infection (STI) clinics to accurately identify antibiotic-resistant strains of pathogens, particularly gonorrhea, which has shown resistance to multiple antibiotics. With approximately 820,000 new gonorrhea infections annually in the United States and the Centers for Disease Control and Prevention designating resistant strains as an urgent threat, Shield Bio's rapid and precise molecular antibiotic susceptibility testing is critical. This platform allows healthcare providers to determine the most effective antibiotics for treatment, thereby enhancing patient outcomes and helping to curb the spread of antibiotic resistance.

Medisas

Series A in 2016
Medisas, Inc., based in the United States, is a company dedicated to improving hospital operations through innovative software solutions. Their cloud-based service facilitates seamless information transfer between doctors during shift changes, ensuring continuity of care. The company's team consists of experienced clinicians, engineers, and designers who are committed to reinventing hospital software. Medisas' record-keeping software focuses on key aspects such as shift change, patient transfer, and discharge, allowing healthcare organizations to maintain organization and enhance the quality of care provided.

PatientPing

Series B in 2016
PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.